|Articles|April 1, 2016
- Pharmaceutical Executive-04-01-2016
- Volume 36
- Issue 4
Pharmaceutical Executive, April 2016 Issue (PDF)
Click the title above to open the Pharmaceutical Executive April 2016 issue in an interactive PDF format.
Advertisement
Articles in this issue
about 10 years ago
Closing the Gaps in Drug Chain of Custodyabout 10 years ago
Data Unleashed: Cooperation Among Competitorsover 10 years ago
Raising the Stakes On Value-Based Pricingover 10 years ago
The Diversity Dearth in Pharmaover 10 years ago
Information in Action: A Conversation with Barbara Lopez Kunzover 10 years ago
R&D Model Mixes Compassion, Calculationover 10 years ago
Pressure Builds to Revamp Off-Label Marketing Rulesover 10 years ago
Drug Compounding: A Cause and Cure for High Drug Prices?over 10 years ago
The Odd Coupleover 10 years ago
Country Report: EgyptAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
FDA Pannel Votes to Loosen Restrictions for Four Peptides
2
Pharmaceutical Executive Daily: FDA Votes to Reduce Restrictions on Four Peptides
3
President Trump Announces Phased Generic Drug Tariff Plan: Report
4
The Business Case for Employer-Based GLP-1 Coverage
5